REFERENCES
1. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50(4):515-25.
2. Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.Cochrane database of systematic reviews 2017(3)
3. McGoldrick E, Stewart F, Parker R, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2020(12)
4. Razaz N, Skoll A, Fahey J, et al. Trends in Optimal, Suboptimal, and Questionably Appropriate Receipt of Antenatal Corticosteroid Prophylaxis. Obstetrics & Gynecology 2015;125(2):288-96.
5. Joseph K, Nette F, Scott H, et al. Prenatal corticosteroid prophylaxis for women delivering at late preterm gestation.Pediatrics 2009;124(5):e835-e43.
6. Liauw J, Burrows J, Crane JM, et al. A Common Language: What Exactly Does 34 Weeks Gestation Mean? Journal of Obstetrics and Gynaecology Canada 2018;40(12):1623-26.
7. Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal betamethasone for women at risk for late preterm delivery. New England Journal of Medicine 2016;374(14):1311-20.
8. Obstetricians ACo, Gynecologists, Practice CoO. Committee opinion no. 677: antenatal corticosteroid therapy for fetal maturation.Obstetrics and gynecology 2016;128(4):e187-e94.
9. Committee SfM-FMP. Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery. Am J Obstet Gynecol 2016;215(2):B13-5.
10. Kerstjens JM, Bocca-Tjeertes IF, de Winter AF, et al. Neonatal morbidities and developmental delay in moderately preterm-born children.Pediatrics 2012;130(2):e265-e72.
11. Souter V, Kauffman E, Marshall AJ, et al. Assessing the potential impact of extending antenatal steroids to the late preterm period.American Journal of Obstetrics and Gynecology 2017;217(4):461. e1-61. e7.
12. Kamath-Rayne BD, Rozance PJ, Goldenberg RL, et al. Antenatal corticosteroids beyond 34 weeks gestation: what do we do now?American journal of obstetrics and gynecology 2016;215(4):423-30.
13. Practice CoO. Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation. Obstetrics and gynecology2017;130(2):e102-e09.
14. Fair M, Cyr M, Allen AC, et al. An assessment of the validity of a computer system for probabilistic record linkage of birth and infant death records in Canada. Chronic Dis Can 2000;21(1):8-13.
15. Prevention. CfDCa. Centers for Disease Control and Prevention Website
2022 [Available from: https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm accessed Accessed May 10, 2022.
16. National Institute of Child Health and Human Development. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH1994;12(2):1-24.
17. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3(3)
18. Crane J, Armson A, Brunner M, et al. Antenatal corticosteroid therapy for fetal maturation. Journal of obstetrics and gynaecology Canada 2003;25(1):45-52.
19. Kearsey EO, Been JV, Souter VL, et al. The impact of the Antenatal Late Preterm Steroids trial on the administration of antenatal corticosteroids. American Journal of Obstetrics and Gynecology2022
20. Leviton LC, Baker S, Hassol A, et al. An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids.American journal of obstetrics and gynecology 1995;173(1):312-16.
21. Schmidt B, Seshia M, Shankaran S, et al. Effects of Prophylactic Indomethacin in Extremely Low-Birth-Weight Infants With and Without Adequate Exposure to Antenatal Corticosteroids. Archives of pediatrics & adolescent medicine 2011;165(7):642-46.
22. Frändberg J, Sandblom J, Bruschettini M, et al. Antenatal corticosteroids: a retrospective cohort study on timing, indications and neonatal outcome. Acta obstetricia et gynecologica Scandinavica2018;97(5):591-97.
23. Norman M, Piedvache A, Børch K, et al. Association of short antenatal corticosteroid administration-to-birth intervals with survival and morbidity among very preterm infants: results from the EPICE cohort.JAMA pediatrics 2017;171(7):678-86.
24. Asztalos EV, Murphy KE, Willan AR, et al. Multiple Courses of Antenatal Corticosteroids for Preterm Birth StudyOutcomes in Children at 5 Years of Age (MACS-5) Antenatal Corticosteroids for Preterm BirthAntenatal Corticosteroids for Preterm Birth. JAMA pediatrics2013;167(12):1102-10.
25. Räikkönen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. Jama 2020;323(19):1924-33.
26. Allouche M, Huissoud C, Guyard-Boileau B, et al. Development and validation of nomograms for predicting preterm delivery. American journal of obstetrics and gynecology 2011;204(3):242. e1-42. e8.
27. DeFranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. American journal of obstetrics and gynecology2013;208(3):233. e1-33. e6.
28. Boots AB, Sanchez-Ramos L, Bowers DM, et al. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis. American journal of obstetrics and gynecology2014;210(1):54. e1-54. e10.
29. Melamed N, Murphy K, Barrett J, et al. Benefit of antenatal corticosteroids by year of birth among preterm infants in Canada during 2003–2017: a population‐based cohort study. BJOG: An International Journal of Obstetrics & Gynaecology 2021;128(3):521-31.
30. Jobe AH, Goldenberg RL. Antenatal corticosteroids: an assessment of anticipated benefits and potential risks. American journal of obstetrics and gynecology 2018;219(1):62-74.
31. Schmidt AF, Kemp MW, Rittenschober-Böhm J, et al. Low-dose betamethasone-acetate for fetal lung maturation in preterm sheep.American journal of obstetrics and gynecology 2018;218(1):132. e1-32. e9.
32. Schmitz T, Doret M, Sentilhes L, et al. LB03 Dose reduction of antenatal betamethasone in women at risk of very preterm delivery (BETADOSE trial). American Journal of Obstetrics & Gynecology2021;224(2):S723-S24.
33. Schmitz T, Alberti C, Ursino M, et al. Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE). BMC pregnancy and childbirth 2019;19(1):1-9.
34. Senat M, Minoui S, Multon O, et al. Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labour: a randomised study. BJOG: An International Journal of Obstetrics & Gynaecology 1998;105(7):749-55.
35. Ninan K, Morfaw F, Murphy KE, et al. Neonatal and Maternal Outcomes of Lower Versus Standard Doses of Antenatal Corticosteroids for Women at Risk of Preterm Delivery: A Systematic Review of Randomized Controlled Trials. Journal of Obstetrics and Gynaecology Canada2021;43(1):74-81.
Figure Legends: